Reactive arthritis

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 1-2, 2009, Pages 60-66

  Kwiatkowska, Brygida ^a   Filipowicz Sosnowska, Anna ^a  

^a INSTITUTE OF RHEUMATOLOGY   (Poland)

Author keywords

Infection related arthritis; Reactive arthritis; Seronegative spondyloarthropathy

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DOXYCYCLINE; HLA B27 ANTIGEN; HYDROCORTISONE; KERATOLYTIC AGENT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RETINOID; RIFAMPICIN; SALAZOSULFAPYRIDINE; STEROID; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL INFECTION; CHLAMYDIA; CHLAMYDIASIS; CLINICAL FEATURE; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG DOSE COMPARISON; DRUG EFFICACY; ENTEROBACTERIACEAE; GRAM NEGATIVE BACTERIUM; HUMAN; JOINT RADIOGRAPHY; KINESIOTHERAPY; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; MYCOPLASMA; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSIOTHERAPY; REACTIVE ARTHRITIS; VIBRIO PARAHAEMOLYTICUS;

EID: 61349173888     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.606     Document Type: Conference Paper

References (42)

1. Colmegna I, Cuchacovic R, Espinoza LR. HLAB27-Assosiated Reactive Arthritis: Pathogenetic and Clinical Considerations. Clin Microbiol Rev. 2004; 17: 348-369.
2. Gottlieb NL, Altman RD. An Ethical dilemma in rheumatology: should the eponym Reiter's syndrome be discarded? Semin Arthritis Rheum. 2003; 32: 207.
3. Aho K. Bowel infection predisposing to reactive arthritis in perspective. Rooney PJ CD, Baillier's, Clin Rheumatol. 1989; 3: 303-319.
4. Nicholls A. Reiter's disease and HLA B27. Ann Rheum Dis. 1975; 34: 27-28.
5. Hannu T, Puolakkainen M, Leirisalo-Repo M. Chamydia pneumonia as a triggering infection in reactive arthritis. Rheumatology. 1999; 38: 411-414.
6. Inman RD, Whittum-Hudson JA, Schumacher HR, et al. Chlamydia associated arthritis. Curr Opin Rheumatol. 2000; 12: 254-262.
7. Khan MA. Update on spondyloarthropaties. Ann Intern Med. 2002; 136: 896-907.
8. Klippel JH, Dieppe PA, et al. Practical rheumatology. Mosby Inc., St Luis 1995.
9. Fox BJ, Sahuquillo MA, Huguet MA, et al. Reactive arthritis with a severe lesion of cervical spine. Br J Rheumatol. 1997; 36:126-129.
10. Huhtinen M, Laasila K, Granfors K, et al. Infectious background of patients with a history of acute anterior uveitis. Ann Rheum Dis. 2002; 61: 1012-1016.
11. Keat A. Reiter's syndrome and reactive arthritis in perspective. N Engl J Med. 1983; 309:1606-1615.
12. Mielants H, Veys EM. The gut and reactive arthritis. Rheumatol Eur. 1995; 12:9-11.
13. Gaston JS, Cox C, Granfors K. Clinical and experimental evidence for persistent Yersinia infection in reactive arthritis. Arthritis Rheum. 1999; 42: 2239-2242.
14. Deer T, Rosenerance G, Chillag S. Cardiac conduction manifestation of Reiter's syndrome. South Med J. 1991; 84: 799-800.
15. Fendler C, Laitko S, Sorensen H, et al. Frequency of triggering bacteria in patients with reactive arthritis and undifferential oliogoarthritis and the relative importance of the tests used for diagnosis. Ann Rheum Dis. 2000; 60: 337-343.
16. Grantors K, Viljanen M, Tiilikainrn A, et al. Persistence of IgM, IgG and IgA antibodies to Yersinia In Yersinia arthritis. J Infect Dis. 1980; 141: 424-429.
17. Maki-lkola O, Leirisalo-Repo M, Kantele P, et al. Salmonella-specyfic antibodies in reactive arthritis. J Infect Dis. 1991; 164:1141-1148.
18. Bas S, Vischer TL. Chlamydia trachomatis antibody detection and diagnosis of reactive arthritis. Br J Rheum. 1998; 37: 1054-1059.
19. Nelson HD, Helfan M. Screening for chlamydial infection. Am J Prev Med. 2001; 20: 95-107.
20. Schnitger K, Njau F, Wittkop U, et al. Staining of Chlamydia trachomatis elementary bodies: a suitable method for identifying infected human monocytes by flow cytometry. J Microbiol Methods. 2007; 69: 116-121.
21. Cuchacovich R, Japa S, Huang WO, et al. Detection of bacterial DNA in Latin American patients with reactive arthritis by polymarese chain reaction and sequencing analysis. J Rheumatol. 2002; 29: 1426-1429.
22. Wilkinson NZ, Kingsley GH, Sieper J, et al. Lack of correlation between the detection of Chlamydia trachomatis DNA in synovial fluid from patients with a range of rheumatic diseases and the presence of an antichlamydial immune response. Arthritis Rheum. 1998; 41:845-854.
23. Colbert RA. HLA-B27 misfolding: a solution to the spondyloarthropathy conundrum? Mol Mede Today. 2000; 6: 224-230.
24. Martel W, Braunstein EM, Borlaza A, et al. Radiologic features of Belter disease. Radiology. 1979; 132: 1-10.
25. Petersel DL, Sigal LH. Reactive arthritis. Infect Dis Clin North Am. 2005; 19: 863-883.
26. Colmegna I, Cuchacovich R, Espinoza LR. HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. 2004; 17: 348-369.
27. Sieper J, Rudwaleit M, Nraun J, et al. Diagnosing reactive arthritis. Role of clinical setting in the value of serologic and microbiologic assays. Arthritis Rheum. 2002; 46: 319-327.
28. Leirisalo M, Skylv G, Kousa M, et al. Follow-up study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum. 1982; 25: 249-259.
29. Fox R, Calin A, Gerber RC, et al. The chronicity of symptoms and disability in Reiter's syndrome: an analysis of 131 consecutive patients. Ann Intern Med. 1979; 91:190-193.
30. Toivanen P. Managing reactive arthritis. Rheumatology. 2000; 39: 117-121.
31. Schumacher HR, Arayssi Jr S, Crane PV, et al. Reactive arthritis. Rheum Dis Clin North Am. 1998; 24: 262-273.
32. Clegg DO, Reda DJ, Weisman MH, et al. Comparison of sulphasalazine and placebo in the treatment of Reactive arthritis (Reiter's syndrome): a Department of Veterans Affairs cooperative study. Arthritis Rheum. 1996; 39: 2021-2027.
33. Rich E, Hook EW, Alarcon GS, et al. Recent advances in the treatment of the seronegative spondyloarthropaties. Curr Rheumatol Rep. 2001; 3: 299-403.
34. Creemers MC, van Riel PL, Franssen MJ, et al. Second-line treatment in seronegative spondyloarthropaties. Semin Arthritis Rheum. 1994; 24: 71-81.
35. Oili KS, Niinisalo H, Korpilahde T, et al. Treatment of reactive arthritis with infliximab. Scan J Rheumatol. 2003; 32: 122-124.
36. Toivanen A, Yli-Kerttula T, Luukkainen R, et al. Effect of antimicrobial treatment on chronic reactive arthritis. Clin Exp Rheumatol. 1993; 11: 301-307.
37. Yli-Kertulla T, Luukkainen R, Yli-Kerttula U, et al. Effect of three month course of ciprofloxacin on the late prognosis of reactive arthritis. Ann Rheum Dis. 2003; 62: 880-884.
38. Hoogkamp-Korstanje JA, Moesker H, Bruyn GA. Ciprofloxacin v placebo for treatment of Yersinia enterocolitica triggered reactive arthritis. Ann Rheum Dis. 2000; 59: 914-917.
39. Kvien TK, Gaston JS, Bardin T, et al. Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study. Ann Rheum Dis. 2004; 63:1113-1119.
40. Carter JD, Valeriano J, Vasey FB. Doxycycline versus doxycycline and rifampin in undifferential spondyloarthropathy, with special reference to Chlamydia-induced arthritis: a prospective, randomized 9-months comparison. J Rheumatol. 2004; 31: 1973-1980.
41. Lauhio A, Leirisalo-Lepo M, Lähdevirta J, et al. Double-blind, placebo-controlled study of three-months treatment with lymecycline in reactive arthritis, with special reference to chlamydia arthritis. Ann Rheum Dis. 2003; 62: 655-658.
42. Ikeda-Dantusij Y, Konomi I, Nagayama A. Effects of levofloxacin and doxycycline on interleukin-6 production of Chlamydia trachomatis - infected human synovial fibroblasts. Chemotherapy. 2007; 53: 332-337.